News | April 13, 2008

Tool Kit Assists in Less-Invasive Valve Repair

April 14, 2008 - ESTECH will showcase its new CG LiV Kits, designed to enable mitral and aortic valve procedures, at the American Association for Thoracic Surgery 88th Annual Meeting in San Diego.

ESTECH in conjunction with New York University Medical Center surgeons, have developed the specialized LiV Kits. The ESTECH CG LiV Kits were developed to allow surgeons to safely and easily implement the advanced heart valve techniques developed at NYU.

The CG LiV Kits include the new ClearView MV Atrial Depressor, Soft Tissue Atraumatic Retractor and EasyFlow Aortic, RAP Femoral Venous and FlexFlow Venous cannula and COBRA Cooled Surgical Probe that reportedly allows surgeons to gain better exposure of the valves, and is designed to enhance the ability for surgeons to do a repair or replacement with the smallest of incisions.

Eugene Grossi, M.D., Professor of Cardiothoracic Surgery at New York University Medical Center, recently published paper in The Annals of Thoracic Surgery that included five year follow-up on 731 patients. "Percutaneous aortic valve replacement (PAVR) trials are ongoing in patients with elevated EuroSCOREs, which are patients believed to have high mortality rates and poor long-term prognoses with valve replacement surgery. However, our results show that the LiV procedure offers surgical results available today in this same target population with a 45 percent reduction in mortality compared with conventional surgery, and excellent five year survival in high risk patients," said Dr. Grossi.

For more information:

Related Content

Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery | May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery | May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Edwards Intuity Elite sutureless aortic valve, first implants in Connecticut, WCHN, Western Connecticut Health Network
News | Cardiovascular Surgery | February 16, 2017
Western Connecticut Health Network (WCHN) cardiothoracic surgeons Cary Passik, M.D., and Robert Gallagher, M.D., were...
Overlay Init